Skip to main content
Signal8

Frazier Life Sciences Management, L.P.

Frazier Life Sciences Management, L.P. is an Investment Adviser institutional filer with the SEC under CIK 1892134, reporting 41 portfolio positions, with 20 historical 13F filings on file. Most recent reporting period: 2026-06-30.

A Form 13F reports a manager's US-listed stock and option positions only. It does not include real estate, private funds, bonds, cash or non-US holdings, so a 13F portfolio value is not the firm's total assets under management (AUM).

  • State of incorporation: DE
  • Filing type: 13F-HR
  • Latest reporting period: 2026-06-30
  • Last filed: 2026-08-14

Top 10 portfolio positions

The largest reported holdings in Frazier Life Sciences Management, L.P.'s most recent 13F filing, ranked by reported market value.

  1. MIRUM PHARMACEUTICALS INC (MIRM)
  2. NEWAMSTERDAM PHARMA COMPANY (NAMS)
  3. ERASCA INC (ERAS)
  4. MBX BIOSCIENCES INC (MBX)
  5. ARCUTIS BIOTHERAPEUTICS INC (ARQT)
  6. TREVI THERAPEUTICS INC (TRVI)
  7. KRYSTAL BIOTECH INC (KRYS)
  8. MAZE THERAPEUTICS INC (MAZE)
  9. PHATHOM PHARMACEUTICALS INC (PHAT)
  10. PALVELLA THERAPEUTICS INC NE (PVLA)
/